癌症支持治疗药物市场规模 - 按药物类别、癌症类型、配销通路、全球预测（2023 - 2032）

由于全球癌症发生率不断上升，预计 2023 年至 2032 年癌症支持治疗药物市场规模的复合年增长率为 1.9%。根据美国癌症统计局的资料，2020年新增癌症病例超过150万例，其中死亡人数近602,347人。随着癌症病例数量持续增加，对减轻癌症治疗副作用的疗法（例如化疗和放射疗法）的需求正在激增。

此外，人们越来越意识到癌症治疗期间生活品质的重要性，也推动了这些药物的使用。随着患者寻求控制症状并保持更高水平的舒适度和幸福感的方法，癌症支持护理解决方案将获得关注。

癌症支持治疗药物市场根据药物类别、癌症类型、配销通路和地区划分。

预计2023 年至2032 年，阿片类药物领域的复合年增长率将达到2.4% 左右。阿片类药物因其在控制癌症相关疼痛方面的有效性而闻名，因此越来越多的患者开始接受阿片类药物的治疗。随着阿片类药物配方的进步，重点已转向实现最佳疼痛缓解，同时最大限度地减少副作用。这不仅提高了患者的舒适度，而且还提供了一种更全面的方法来管理癌症症状。

肺癌领域预计在 2023 年和 2032 年期间复合年增长率为 2.5%，因为它是最受欢迎和最具侵袭性的癌症类型之一。肺癌患者常常会出现一系列令人痛苦的症状，包括疼痛、呼吸困难和疲劳。因此，对针对肺癌患者特定需求的支持性护理药物的需求很高。用于改善患者生活品质的肺癌创新药物和疗法的开发正在推动该行业的成长。

受惠于强大的医疗基础设施、广泛的研发活动和高癌症盛行率，北美癌症支持治疗药物产业预计 2023 年至 2032 年复合年增长率为 1.7%。美国和加拿大处于推动癌症支持治疗的最前沿，大力投资研发，并确保患者能够获得最新、最有效的支持性治疗药物。北美对癌症治疗期间患者舒适度和福祉的重视将继续推动市场扩张。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：癌症支持治疗药物市场产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 癌症发生率和盛行率上升
    • 癌症治疗技术不断进步
    • 老年人口不断增加
    • 数位健康日益一体化
    • 提高患者和医疗保健专业人员对支持性护理药物的可用性和益处的认识
  • 产业陷阱与挑战
    • 替代疗法或补充疗法的可用性
    • 医疗资源有限
    • 不良反应药物
• 成长潜力分析
• COVID-19 影响分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司定位矩阵
• 主要市场参与者的竞争分析
• 战略仪表板

第 5 章：癌症支持治疗药物市场规模和预测：按药物类别

• 主要动向：依药物类别
• G-CSF（粒细胞集落刺激因子）
• ESA（红血球生成刺激剂）
• 止吐药
• 双磷酸盐
• 阿片类药物
• 非类固醇抗发炎药
• 其他药品

第 6 章：癌症支持治疗药物市场规模与预测：按癌症类型

• 主要动力向：按癌症类型
• 乳癌
• 肺癌
• 黑色素瘤
• 摄护腺癌
• 大肠直肠癌
• 肝癌
• 胃癌
• 其他癌症类型

第 7 章：癌症支持治疗药物市场规模及预测：按分销管道

• 主要动向：按配销通路
• 医院药房
• 药局和零售药局
• 网路药局

第 8 章：癌症支持治疗药物市场规模与预测：按地区

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 中东和非洲其他地区

第 9 章：公司简介

• Amgen, Inc.
• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Heron Therapeutics, Inc.
• Novartis AG
• GSK plc
• F. Hoffmann-La Roche Ltd.
• Helsinn Healthcare SA
• Teva Pharmaceuticals Industries Ltd.
• Fagron Group

Cancer supportive care drugs market size is predicted to witness 1.9% CAGR from 2023 to 2032 due to the escalating incidence of cancer worldwide. According to the data from the United States Cancer Statistics, more than 1.5 million new cancer cases were reported in 2020, out of which nearly 602,347 deaths were reported. As the number of cancer cases continues to rise, the demand for therapies that alleviate the side effects of cancer treatment, such as chemotherapy and radiation therapy, is surging.

Additionally, the growing awareness about the importance of quality of life during cancer treatment has fueled the usage of these drugs. As patients seek ways to manage their symptoms and maintain a higher level of comfort and well-being, the cancer support care solutions will gain traction.

Cancer supportive care drugs market is divided based on drug class, cancer type, distribution channel, and region.

The opioids segment is expected to record around 2.4% CAGR from 2023 to 2032. As opioids are known for their effectiveness in managing cancer-related pain, they are increasingly prescribed to patients undergoing cancer treatment. With advancements in opioid formulations, the focus has shifted toward achieving optimal pain relief while minimizing side effects. This is not only enhancing patient comfort but also providing a more comprehensive approach to managing cancer symptoms.

The lung cancer segment is anticipated to observe 2.5% CAGR during 2023 and 2032 as it is one of the most prevalent and aggressive types of cancer. Patients with lung cancer often suffer from a range of distressing symptoms, including pain, breathlessness, and fatigue. As a result, there is a high demand for supportive care drugs tailored to the specific needs of lung cancer patients. The development of innovative drugs and therapies for lung cancer for improving the quality of life for patients is driving the industry growth.

North America cancer supportive care drugs industry is expected to witness 1.7% CAGR from 2023 to 2032, favored by a robust healthcare infrastructure, extensive R&D activities, and high cancer prevalence. The United States and Canada are at the forefront of advancing cancer supportive care, investing heavily in R&D, and ensuring that patients have access to the latest and most effective supportive care drugs. The emphasis on patient comfort and well-being during cancer treatment in North America will continue to drive the market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Forecast parameters
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Global cancer supportive care drugs market 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Drug class trends
  • 2.1.4 Cancer type trends
  • 2.1.5 Distribution channel trends

Chapter 3 Cancer Supportive Care Drugs Market Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence and prevalence of cancer
    • 3.2.1.2 Increasing technological advancements in cancer therapies
    • 3.2.1.3 Rising geriatric population
    • 3.2.1.4 Growing integration of digital health
    • 3.2.1.5 Increasing awareness among patients and healthcare professionals about the availability and benefits of supportive care drugs
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Availability of alternative therapies or complementary treatments
    • 3.2.2.2 Limited healthcare resources
    • 3.2.2.3 Adverse effect drugs
• 3.3 Growth potential analysis
  • 3.3.1 By drug class
  • 3.3.2 By cancer type
  • 3.3.3 By distribution channel
• 3.4 COVID- 19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Company positioning matrix, 2022
• 4.4 Competitive analysis of major market players, 2022
• 4.5 Strategy dashboard, 2022

Chapter 5 Cancer Supportive Care Drugs Market Size and Forecast, By Drug class (USD Million)

• 5.1 Key trends, by drug class
• 5.2 G-CSFs (Granulocyte-colony Stimulating Factors)
• 5.3 ESAs (Erythropoiesis Stimulating Agents)
• 5.4 Anti-emetics
• 5.5 Bisphosphonates
• 5.6 Opioids
• 5.7 NSAIDs
• 5.8 Other drugs

Chapter 6 Cancer Supportive Care Drugs Market Size and Forecast, By Cancer type (USD Million)

• 6.1 Key trends, by cancer type
• 6.2 Breast cancer
• 6.3 Lung cancer
• 6.4 Melanoma
• 6.5 Prostate cancer
• 6.6 Colorectal cancer
• 6.7 Liver cancer
• 6.8 Stomach cancer
• 6.9 Other cancer types

Chapter 7 Cancer Supportive Care Drugs Market Size and Forecast, By Distribution channel (USD Million)

• 7.1 Key trends, by distribution channel
• 7.2 Hospital pharmacies
• 7.3 Drug stores and retail pharmacies
• 7.4 Online pharmacies

Chapter 8 Cancer Supportive Care Drugs Market Size and Forecast, By Region (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Amgen, Inc.
• 9.2 Merck & Co., Inc.
• 9.3 Johnson & Johnson Services, Inc.
• 9.4 Heron Therapeutics, Inc.
• 9.5 Novartis AG
• 9.6 GSK plc
• 9.7 F. Hoffmann-La Roche Ltd.
• 9.8 Helsinn Healthcare SA
• 9.9 Teva Pharmaceuticals Industries Ltd.
• 9.10 Fagron Group

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by drug class (2022)
• TABLE 3 Market share, by cancer type (2022)
• TABLE 4 Market share, by distribution channel (2022)
• TABLE 5 Global cancer supportive care drugs market size, by region, 2018-2022 (USD Million)
• TABLE 6 Global cancer supportive care drugs market size, by region, 2023-2032 (USD Million)
• TABLE 7 Global cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 8 Global cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 9 Global cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 10 Global cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 11 Global cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 12 Global cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 13 Industry impact forces
• TABLE 14 G-CSFs (Granulocyte-colony Stimulating Factors) market size, 2018-2022 (USD Million)
• TABLE 15 G-CSFs (Granulocyte-colony Stimulating Factors) market size, 2023-2032 (USD Million)
• TABLE 16 ESAs (Erythropoiesis Stimulating Agents) market size, 2018-2022 (USD Million)
• TABLE 17 ESAs (Erythropoiesis Stimulating Agents) market size, 2023-2032 (USD Million)
• TABLE 18 Anti-emetics market size, 2018-2022 (USD Million)
• TABLE 19 Anti-emetics market size, 2023-2032 (USD Million)
• TABLE 20 Bisphosphonates market size, 2018-2022 (USD Million)
• TABLE 21 Bisphosphonates market size, 2023-2032 (USD Million)
• TABLE 22 Opioids market size, 2018-2022 (USD Million)
• TABLE 23 Opioids market size, 2023-2032 (USD Million)
• TABLE 24 NSAIDs market size, 2018-2022 (USD Million)
• TABLE 25 NSAIDs market size, 2023-2032 (USD Million)
• TABLE 26 Other drugs market size, 2018-2022 (USD Million)
• TABLE 27 Other drugs market size, 2023-2032 (USD Million)
• TABLE 28 Breast cancer market size, 2018-2022 (USD Million)
• TABLE 29 Breast cancer market size, 2023-2032 (USD Million)
• TABLE 30 Lung cancer market size, 2018-2022 (USD Million)
• TABLE 31 Lung cancer market size, 2023-2032 (USD Million)
• TABLE 32 Melanoma market size, 2018-2022 (USD Million)
• TABLE 33 Melanoma market size, 2023-2032 (USD Million)
• TABLE 34 Prostate cancer market size, 2018-2022 (USD Million)
• TABLE 35 Prostate cancer market size, 2023-2032 (USD Million)
• TABLE 36 Stomach cancer market size, 2018-2022 (USD Million)
• TABLE 37 Stomach cancer market size, 2023-2032 (USD Million)
• TABLE 38 Liver cancer market size, 2018-2022 (USD Million)
• TABLE 39 Liver cancer market size, 2023-2032 (USD Million)
• TABLE 40 Colorectal cancer market size, 2018-2022 (USD Million)
• TABLE 41 Colorectal cancer market size, 2023-2032 (USD Million)
• TABLE 42 Other cancer types market size, 2018-2022 (USD Million)
• TABLE 43 Other cancer types market size, 2023-2032 (USD Million)
• TABLE 44 Hospital pharmacies market size, 2018-2022 (USD Million)
• TABLE 45 Hospital pharmacies market size, 2023-2032 (USD Million)
• TABLE 46 Drug stores and retail pharmacies market size, 2018-2022 (USD Million)
• TABLE 47 Drug stores and retail pharmacies market size, 2023-2032 (USD Million)
• TABLE 48 Online pharmacies market size, 2018-2022 (USD Million)
• TABLE 49 Online pharmacies market size, 2023-2032 (USD Million)
• TABLE 50 North America cancer supportive care drugs market size, by country, 2018-2022 (USD Million)
• TABLE 51 North America cancer supportive care drugs market size, by country, 2023-2032 (USD Million)
• TABLE 52 North America cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 53 North America cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 54 North America cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 55 North America cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 56 North America cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 57 North America cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 58 U.S. cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 59 U.S. cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 60 U.S. cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 61 U.S. cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 62 U.S. cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 63 U.S. cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 64 Canada cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 65 Canada cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 66 Canada cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 67 Canada cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 68 Canada cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 69 Canada cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 70 Europe cancer supportive care drugs market size, by country, 2018-2022 (USD Million)
• TABLE 71 Europe cancer supportive care drugs market size, by country, 2023-2032 (USD Million)
• TABLE 72 Europe cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 73 Europe cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 74 Europe cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 75 Europe cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 76 Europe cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 77 Europe cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 78 Germany cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 79 Germany cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 80 Germany cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 81 Germany cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 82 Germany cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 83 Germany cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 84 U.K. cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 85 U.K. cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 86 U.K. cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 87 U.K. cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 88 U.K. cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 89 U.K. cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 90 France cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 91 France cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 92 France cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 93 France cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 94 France cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 95 France cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 96 Spain cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 97 Spain cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 98 Spain cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 99 Spain cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 100 Spain cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 101 Spain cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 102 Italy cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 103 Italy cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 104 Italy cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 105 Italy cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 106 Italy cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 107 Italy cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 108 Rest of Europe cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 109 Rest of Europe cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 110 Rest of Europe cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 111 Rest of Europe cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 112 Rest of Europe cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 113 Rest of Europe cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 114 Asia Pacific cancer supportive care drugs market size, by country, 2018-2022 (USD Million)
• TABLE 115 Asia Pacific cancer supportive care drugs market size, by country, 2023-2032 (USD Million)
• TABLE 116 Asia Pacific cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 117 Asia Pacific cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 118 Asia Pacific cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 119 Asia Pacific cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 120 Asia Pacific cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 121 Asia Pacific cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 122 Japan cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 123 Japan cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 124 Japan cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 125 Japan cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 126 Japan cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 127 Japan cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 128 China cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 129 China cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 130 China cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 131 China cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 132 China cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 133 China cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 134 India cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 135 India cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 136 India cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 137 India cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 138 India cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 139 India cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 140 Australia cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 141 Australia cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 142 Australia cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 143 Australia cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 144 Australia cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 145 Australia cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 146 Rest of Asia Pacific cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 147 Rest of Asia Pacific cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 148 Rest of Asia Pacific cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 149 Rest of Asia Pacific cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 150 Rest of Asia Pacific cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 151 Rest of Asia Pacific cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 152 Latin America cancer supportive care drugs market size, by country, 2018-2022 (USD Million)
• TABLE 153 Latin America cancer supportive care drugs market size, by country, 2023-2032 (USD Million)
• TABLE 154 Latin America cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 155 Latin America cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 156 Latin America cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 157 Latin America cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 158 Latin America cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 159 Latin America cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 160 Brazil cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 161 Brazil cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 162 Brazil cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 163 Brazil cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 164 Brazil cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 165 Brazil cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 166 Mexico cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 167 Mexico cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 168 Mexico cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 169 Mexico cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 170 Mexico cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 171 Mexico cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 172 Rest of Latin America cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 173 Rest of Latin America cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 174 Rest of Latin America cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 175 Rest of Latin America cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 176 Rest of Latin America cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 177 Rest of Latin America cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 178 Middle East & Africa cancer supportive care drugs market size, by country, 2018-2022 (USD Million)
• TABLE 179 Middle East & Africa cancer supportive care drugs market size, by country, 2023-2032 (USD Million)
• TABLE 180 Middle East & Africa cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 181 Middle East & Africa cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 182 Middle East & Africa cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 183 Middle East & Africa cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 184 Middle East & Africa cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 185 Middle East & Africa cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 186 South Africa cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 187 South Africa cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 188 South Africa cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 189 South Africa cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 190 South Africa cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 191 South Africa cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 192 Saudi Arabia cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 193 Saudi Arabia cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 194 Saudi Arabia cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 195 Saudi Arabia cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 196 Saudi Arabia cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 197 Saudi Arabia cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)
• TABLE 198 Rest of Middle East & Africa cancer supportive care drugs market size, by drug class, 2018-2022 (USD Million)
• TABLE 199 Rest of Middle East & Africa cancer supportive care drugs market size, by drug class, 2023-2032 (USD Million)
• TABLE 200 Rest of Middle East & Africa cancer supportive care drugs market size, by cancer type, 2018-2022 (USD Million)
• TABLE 201 Rest of Middle East & Africa cancer supportive care drugs market size, by cancer type, 2023-2032 (USD Million)
• TABLE 202 Rest of Middle East & Africa cancer supportive care drugs market size, by distribution channel, 2018-2022 (USD Million)
• TABLE 203 Rest of Middle East & Africa cancer supportive care drugs market size, by distribution channel, 2023-2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Cancer supportive care drugs industry 36 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by drug class
• FIG 8 Growth potential analysis, by cancer type
• FIG 9 Growth potential analysis, by distribution
• FIG 10 Porter's analysis
• FIG 11 PESTEL analysis
• FIG 12 Company matrix analysis, 2022
• FIG 13 Competitive analysis of major market players, 2022
• FIG 14 Competitive positioning matrix, 2022
• FIG 15 Strategic dashboard, 2022